[1]MAKKER V,MACKAY H,RAY-COQUARD I,et al.Endometrial cancer[J].Nat Rev Dis Primers,2021,7(1):88.
[2]YAN H,BU P.Non-coding RNA in cancer[J].Essays Biochem,2021,65(4):625-639.
[3]BIENKIEWICZ J,ROMANOWICZ H,SZYMANSKA B,et al.Analysis of lncRNA sequences:FAM3D-AS1,LINC01230,LINC01315 and LINC01468 in endometrial cancer[J].BMC Cancer,2022,22(1):343.
[4]HE Y,XU S,QI Y,et al.Long noncoding RNA SNHG25 promotes the malignancy of endometrial cancer by sponging microRNA-497-5p and increasing FASN expression[J].J Ovarian Res,2021,14(1):163.
[5]ZHAO X,CHEN L,WU J,et al.Transcription factor KLF15 inhibits the proliferation and migration of gastric cancer cells via regulating the TFAP2A-AS1/NISCH axis[J].Biol Direct,2021,16(1):21.
[6]ZHANG Y,MA L,ZHANG T,et al.Long noncoding RNA TFAP2A AS1 exerts promotive effects in non small cell lung cancer progression via controlling the microRNA 548a-3p/CDK4 axis[J].Oncol Res,2022,31(2):1-5.
[7]ZHOU B,GUO H,TANG J.Long non-coding RNA TFAP2A-AS1 inhibits cell proliferation and invasion in breast cancer via miR-933/SMAD2[J].Med Sci Monit,2019,25(3):1242-1253.
[8]YANG K,NIU Y,CUI Z,et al.Long noncoding RNA TFAP2A-AS1 promotes oral squamous cell carcinoma cell growth and movement via competitively binding miR-1297 and regulating TFAP2A expression[J].Mol Carcinog,2022,22(3):23-27.
[9]WANG L,CUI M,CHENG D,et al.miR-9-5p facilitates hepatocellular carcinoma cell proliferation,migration and invasion by targeting ESR1[J].Mol Cell Biochem,2021,476(2):575-583.
[10]ZHU K,LIN J,CHEN S,et al.miR-9-5p promotes lung adenocarcinoma cell proliferation,migration and invasion by targeting ID4[J].Technol Cancer Res Treat,2021,20(4):15330338211048592.
[11]李林,魏旭静,路素双,等.LncRNA CCAT1通过MAPK/ERK通路影响子宫内膜癌细胞的侵袭转移[J].中国免疫学杂志,2021,37(12):1477-1481.
LI L,WEI XJ,LU SS,et al.LncRNA CCAT1 affects the invasion and metastasis of endometrial cancer cells through the MAPK/ERK pathway[J].Chinese Journal of Immunology,2021,37(12):1477-1481.
[12]CHENG Y,SHI W,CUI X,et al.Long noncoding RNA TFAP2A-AS1 suppressed hepatitis B virus replication by modulating miR-933/HDAC11[J].Dis Markers,2022,2022(4):7733390.
[13]JIE G,PENG S,CUI Z,et al.Long non-coding RNA TFAP2A-AS1 plays an important role in oral squamous cell carcinoma:Research includes bioinformatics analysis and experiments[J].BMC Oral Health,2022,22(1):160.
[14]ASL ER,AMINI M,NAJAFI S,et al.Interplay between MAPK/ERK signaling pathway and MicroRNAs:A crucial mechanism regulating cancer cell metabolism and tumor progression[J].Life Sci,2021,278(14):119499.
[15]SUGIURA R,SATOH R,TAKASAKI T.ERK:A double-edged sword in cancer.ERK-dependent apoptosis as a potential therapeutic strategy for cancer[J].Cells,2021,10(10):2509.
[16] 陈少源,刘荣志,杨子仪,等.miR-146a-5p调控P38/ERK1/Smad3通路对巨噬细胞表型的影响[J].中华实用诊断与治疗杂志,2021,35(9):901-905.
CHEN SY,LIU RZ,YANG ZY,et al.The effect of miR-146a-5p regulation of the P38/ERK1/Smad3 pathway on macrophage phenotype[J].Chinese Journal of Practical Diagnosis and Treatment,2021,35(9):901-905.
[17] 刘耿,李永坤,刘洪锋.miR-106a-5p靶向ERK2逆转胃癌细胞MGC-803对顺铂化疗的耐药性[J].安徽医科大学学报,2020,55(5):722-728.
LIU G,LI YK,LIU HF.miR-106a-5p targeting ERK2 reverses the resistance of gastric cancer cell line MGC-803 to cisplatin chemotherapy[J].Journal of Anhui Medical University,2020,55(5):722-728.
[18]张慧君,陆周一,王邵华,等.miR-138介导ERK和AKT对NSCLC细胞株A549增殖和迁移的作用机制研究[J].中国肿瘤临床与康复,2020,27(2):138-142.
ZHANG HJ,LU ZY,WANG SH,et al.The mechanism of miR-138 mediated ERK and AKT on the proliferation and migration of NSCLC cell line A549[J].Chinese Journal of Oncology Clinical and Rehabilitation,2020,27(2):138-142.
[19]罗成,杨林,邹永根.miR-152通过调节AKT-ERK信号通路对骨肉瘤细胞增殖和迁移的影响[J].现代肿瘤医学,2019,27(21):3752-3756.
LUO C,YANG L,ZOU YG.Effects of miR-152 on proliferation and migration of osteosarcoma cells by regulating AKT-ERK signaling pathway[J].Modern Oncology,2019,27(21):3752-3756.